X
Xiangya Biopharmaceutical (Huzhou)
Fermented enzyme supplements promoting digestive health and overall wellness
About Xiangya Biopharmaceutical (Huzhou)
Xiangya Biopharmaceutical (Huzhou) Co., Ltd. is a researcher and provider of medical cosmetology services operating within the protein repair industry. The company was established in 2020 and has its headquarters in Huzhou, China.
The firm's core activities revolve around the research and development of medical devices and new drugs. Its primary focus areas are wound repair, medical cosmetology, and applications in serious medical care. Xiangya Biopharmaceutical aims to deliver high-standard products and services to its clientele.
From a financial perspective, the company is privately held and is currently in a revenue-generating stage. It has successfully attracted venture capital, securing $13.9 million in a Series A funding round in May 2024. This followed an earlier undisclosed early-stage venture capital round in April 2024. Key investors in the company include Zhuhai Technology Venture Capital and Meilai Medical.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Open positions
- None listed
- Dealroom signal
- 20.3/100
- Industry
- Health
- Sub-industry
- Pharmaceutical, BioTechnology
- Sector
- Biotechnology, Spinout, Biotech and Pharma, DT and LS, science-based
- Business model
- Manufacturing
- Client focus
- B2B
- Links
- Website
News
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES A✓Equity / VC | May 2024 | $14M | $55M | Haisheng Fund · Huzhou Economic Development | ↗ |
| EARLY VC✓Equity / VC | Apr 2024 | $0 | — | MyLai Medical Group | ↗ |
Growth signals
Latest recorded traffic for Xiangya Biopharmaceutical (Huzhou) is 160 monthly website visits.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Xiangya Biopharmaceutical (Huzhou) in its local ecosystem
The Xiangya Biopharmaceutical (Huzhou) office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A3 investors entered at this stage
- MGMyLai Medical Group
- HFHaisheng Fund
- HDHuzhou Economic Development
Other known investors1 additional known investor
Central South University
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Xiangya Biopharmaceutical (Huzhou) on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Xiangya Biopharmaceutical (Huzhou)’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.








